BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19452544)

  • 1. Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome.
    Nassar H; Sharafaldeen B; Visvanathan K; Visscher D
    Cancer; 2009 Jul; 115(14):3181-8. PubMed ID: 19452544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtypes of ductal carcinoma in situ in African American and Caucasian American women: distribution and correlation with pathological features and outcome.
    Sharaf Aldeen B; Feng J; Wu Y; Nassar Warzecha H
    Cancer Epidemiol; 2013 Aug; 37(4):474-8. PubMed ID: 23639792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
    Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
    Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women.
    Stark A; Stapp R; Raghunathan A; Yan X; Kirchner HL; Griggs J; Newman L; Chitale D; Dick A
    Breast Cancer Res Treat; 2012 Jan; 131(2):561-70. PubMed ID: 21874310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.
    Bailes AA; Kuerer HM; Lari SA; Jones LA; Brewster AM
    Cancer; 2013 Jan; 119(1):150-7. PubMed ID: 22736444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
    J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
    Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
    Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
    Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study.
    Vidali C; Caffo O; Aristei C; Bertoni F; Bonetta A; Guenzi M; Iotti C; Leonardi MC; Mussari S; Neri S; Pietta N
    Radiat Oncol; 2012 Oct; 7():177. PubMed ID: 23098066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
    Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
    ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
    Joslyn SA
    Breast J; 2006; 12(1):20-7. PubMed ID: 16409583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.
    Moran MS; Yang Q; Harris LN; Jones B; Tuck DP; Haffty BG
    Cancer; 2008 Nov; 113(9):2565-74. PubMed ID: 18816610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
    Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG
    Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal Carcinoma In Situ - Quo Vadis?
    Peltecu G
    Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.